Clinical Trials Directory

Trials / Sponsors / Brii Biosciences Limited

Brii Biosciences Limited

Industry · 11 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Parti
Chronic Hepatitis B Virus (HBV) Infection
Phase 22024-10-31
Active Not RecruitingStudy to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating
For Treatment of Chronic Hepatitis B Virus Infection
Phase 22024-08-06
CompletedA Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)
Severe Postpartum Depression
Phase 22023-09-29
Active Not RecruitingInvestigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Pat
Chronic Hepatitis B Virus Infection
Phase 22023-08-22
CompletedA Study of BRII-297 in Healthy Adult Subjects
Postpartum Depression
Phase 12023-05-15
CompletedA Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
COVID-19
Phase 22021-06-20
CompletedStudy to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hep
Hepatitis B, Chronic
Phase 22021-04-12
CompletedA Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
COVID-19
Phase 12021-01-05
CompletedStudy of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China
Hepatitis B, Chronic
Phase 22020-08-18
CompletedSafety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198
COVID-19
Phase 12020-07-13
CompletedSafety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196
COVID-19
Phase 12020-07-12